Data_Sheet_4_Combination of a Latency-Reversing Agent With a Smac Mimetic Minimizes Secondary HIV-1 Infection in vitro.PDF
Latency-reversing agents (LRAs) are considered a potential tool to cure human immunodeficiency virus type 1 (HIV-1) infection, but when they are taken alone, virus production by reactivated cells and subsequent infection will occur. Hence, it is crucial to simultaneously take appropriate measures to prevent such secondary HIV-1 infection. In this regard, a strategy to minimize the production of infectious viruses from LRA-reactivated cells is worth pursuing. Here, we focused on a second mitochondria-derived activator of caspases (Smac) mimetic, birinapant, to induce apoptosis in latent HIV-1-infected cells. When birinapant was administered alone, it only slightly increased the expression of caspase-3. However, in combination with an LRA (e.g., PEP005), it strongly induced the expression of caspase-3 followed by enhanced apoptosis. Importantly, the combination eliminated reactivated cells and drastically reduced HIV-1 production. Finally, we found that birinapant decreased the mRNA expression of HIV-1 that was induced by PEP005 in the primary CD4+ T-cells from HIV-1-carrying patients as well. These results suggest that the combination of an LRA and an “apoptosis-inducing” agent, such as a Smac mimetic, is a possible treatment option to decrease HIV-1 reservoirs without the occurrence of HIV-1 production by reactivated cells.
History
References
- https://doi.org//10.1007/s10549-012-2352-6
- https://doi.org//10.1186/s12876-017-0726-2
- https://doi.org//10.1038/nature11286
- https://doi.org//10.1038/cddis.2013.248
- https://doi.org//10.1016/j.pharmthera.2014.05.007
- https://doi.org//10.1158/1535-7163.MCT-13-0798
- https://doi.org//10.1016/j.chom.2016.11.001
- https://doi.org//10.1038/nm.3489
- https://doi.org//10.1093/jnci/djt440
- https://doi.org//10.1146/annurev-pharmtox-010510-100237
- https://doi.org//10.1016/j.coviro.2016.02.001
- https://doi.org//10.1073/pnas.1402873111
- https://doi.org//10.1021/jm500176w
- https://doi.org//10.1126/science.1250220
- https://doi.org//10.1016/j.it.2016.12.003
- https://doi.org//10.1186/1742-4690-10-11
- https://doi.org//10.1016/j.molcel.2010.10.023
- https://doi.org//10.1073/pnas.1502400112
- https://doi.org//10.1016/S2352-3018(15)00226-X
- https://doi.org//10.1038/nrd3627
- https://doi.org//10.1097/QAD.0000000000001064
- https://doi.org//10.1111/j.1574-6976.2012.00335.x
- https://doi.org//10.1128/AAC.00270-09
- https://doi.org//10.1371/journal.ppat.1005066
- https://doi.org//10.1097/COH.0b013e328340ffbb
- https://doi.org//10.1016/j.biocel.2008.04.007
- https://doi.org//10.1186/s12977-015-0169-1
- https://doi.org//10.1158/1078-0432.CCR-12-2518
- https://doi.org//10.1172/JCI80142
- https://doi.org//10.1093/jac/dkt471
- https://doi.org//10.3851/IMP2697
- https://doi.org//10.1016/j.bbrc.2014.12.102
- https://doi.org//10.1016/j.virol.2014.02.008
- https://doi.org//10.1016/j.chom.2015.08.009
- https://doi.org//10.1016/j.chom.2015.08.009
- https://doi.org//10.1016/S2352-3018(14)70014-1
- https://doi.org//10.1016/j.coi.2011.08.002
- https://doi.org//10.1128/AAC.01077-15
- https://doi.org//10.1038/s41598-017-09129-w
- https://doi.org//10.1172/JCI39199
- https://doi.org//10.3892/ijo.2014.2725